Magnetar Financial’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-644,894
| Closed | -$63.5M | – | 878 |
|
|
2025
Q2 | $63.5M | Buy |
644,894
+6,696
| +1% | +$634K | 0.31% | 19 |
|
|
2025
Q1 | $59.1M | Buy |
638,198
+755
| +0.1% | +$69.6K | 0.78% | 15 |
|
|
2024
Q4 | $57.9M | Buy |
637,443
+1,835
| +0.3% | +$169K | 1.33% | 20 |
|
|
2024
Q3 | $61.3M | Buy |
635,608
+20,113
| +3% | +$1.96M | 1.33% | 23 |
|
|
2024
Q2 | $56.5M | Sell |
615,495
-3,416
| -0.6% | -$317K | 1.18% | 28 |
|
|
2024
Q1 | $57M | Hold |
618,911
| – | – | 1.28% | 23 |
|
|
2023
Q4 | $58.8M | Buy |
618,911
+11,051
| +2% | +$1.03M | 1.49% | 16 |
|
|
2023
Q3 | $56.8M | Buy |
607,860
+36,379
| +6% | +$3.36M | 1.45% | 22 |
|
|
2023
Q2 | $52.3M | Buy |
571,481
+558,660
| +4,357% | +$45.8M | 1.15% | 29 |
|
|
2023
Q1 | $943K | Sell |
12,821
-9,979
| -44% | -$863K | 0.02% | 386 |
|
|
2022
Q4 | $1.91M | Buy |
+22,800
| New | +$2.06M | 0.03% | 418 |
|
|
2022
Q3 | – | Sell |
-5,448
| Closed | -$573 | – | 1359 |
|
|
2022
Q2 | $573 | Buy |
+5,448
| New | +$696K | 0.01% | 1107 |
|
|
2022
Q1 | – | Sell |
-1,591
| Closed | -$258K | – | 1315 |
|
|
2021
Q4 | $258K | Buy |
+1,591
| New | +$256K | ﹤0.01% | 1096 |
|
|
2021
Q3 | – | Sell |
-3,080
| Closed | -$754 | – | 1302 |
|
|
2021
Q2 | $754 | Buy |
+3,080
| New | +$808K | 0.01% | 782 |
|
|
2019
Q4 | – | Sell |
-44,153
| Closed | -$5.78M | – | 528 |
|
|
2019
Q3 | $5.78M | Buy |
44,153
+6,653
| +18% | +$866K | 0.15% | 97 |
|
|
2019
Q2 | $4.55M | Buy |
+37,500
| New | +$4.45M | 0.09% | 98 |
|
|
2018
Q4 | – | Sell |
-4,138
| Closed | -$517K | – | 280 |
|
|
2018
Q3 | $517K | Buy |
+4,138
| New | +$457K | 0.01% | 194 |
|
Other funds holding AMED
IA
MCI
HNB
Magnetar Financial's AMED Position: Q3 2025 in Review
Magnetar Financial sold out of Amedisys (AMED) in Q3 2025, closing a stake of 644,894 shares — an estimated $63.5M sold.
Magnetar Financial first reported a position in AMED in Q3 2018 and held it in 17 quarters. The position peaked at $63.5M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Magnetar Financial reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Magnetar Financial sold 644,894 Amedisys shares in Q3 2025, an estimated $63.5M.
- Magnetar Financial first reported a position in Amedisys in Q3 2018 and held it in 17 quarters.
- Magnetar Financial's Amedisys position peaked at $63.5M in Q2 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Magnetar Financial's 13F filing for Q3 2025, filed 13 Nov 2025.